Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Baicalin may help reduce excessive male hormone levels in PCOS.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Removing the ovarian tumor improved the woman's hormonal symptoms.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

Acute illnesses like sepsis can disrupt thyroid hormone balance without central hypothyroidism.